Design, synthesis, and antiviral evaluation of 2-deoxy-D-ribosides of substituted benzimidazoles as potential agents for human cytomegalovirus infections

Nucleosides, Nucleotides and Nucleic Acids

Volumn 19, Issue 1-2, 2000, Pages 125-153

  Zou, Ruiming ^b   Kawashima, Etsuko ^c   Freeman, George A ^a   Koszalka, George W ^a   Drach, John C ^d   Townsend, Leroy B ^d  

^a GLAXOSMITHKLINE   (United States)

^b GILEAD SCIENCES   (United States)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 DEOXY BETA DEXTRO ERYTHRO PENTOFURANOSYL) 5,6 DICHLORO 2 ISOPROPYLAMINOBENZIMIDAZOLE; 2 AMINO 5,6 DICHLORO 1 (2 DEOXY BETA DEXTRO ERYTHRO PENTOFURANOSYL)BENZIMIDAZOLE; 2 AZIDO 5,6 DICHLORO 1 (2 DEOXY BETA DEXTRO ERYTHRO PENTOFURANOZYL)BENZIMIDAZOLE; 2 BROMO 5,6 DICHLORO 1 (2 DEOXY BETA DEXTRO ERYTHRO PENTOFURANOSYL)BENZIMIDAZOLE; 2,5,6 TRICHLORO 1 (2 DEOXY BETA DEXTRO ERYTHRO PENTOFURANOSYL)BENZIMIDAZOLE; 2,5,6 TRICHLORO 1 BETA DEXTRO RIBOFURANOSYLBENZIMIDAZOLE; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DNA VIRUS; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HERPES SIMPLEX VIRUS 1; PROTEIN GLYCOSYLATION; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOCHEMISTRY;

CYTOMEGALOVIRUS; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5;

EID: 0034110178     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1080/15257770008033000     Document Type: Article

References (39)

1. Britt, W. J.; Alford, C. A. Cytomegalovirus, p 2493-2523. In B.N. Fields, D.M. Knipe, and P.M. Howley (ed.), Fields Virology, 3rd ed., 1996. Lippincott - Raven Publishers, Philadelphia, PA.
2. Crumpacker, C. S. Ganciclovir. New England Journal of Medicine 1996; 335:721-729.
3. Chrisp, P.; Clissold, S. P. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991; 41, 104-129.
4. Hitchcock, M. J.; Jaffe, H. S.; Martin, J. C.; Stagg, R. J. Cidofovir, a new agent with potent anti-herpesvirus activity. Antiviral Chemistry & Chemotherapy 1996; 7:115-127.
5. Marwick, C. First "antisense" drug will treat CMV retinitis. J. Amer. Med. Assn. 1998 280:871.
6. Skolnik, P. R.; Hirsch, M. S. Therapy and Prevention of Cytomegalovirus Infections. In "Clinical Use of Antiviral Drugs", DeClercq, E. Ed., Martinus Nijhoff Publishing, Norwell, 1988, pp. 159-194.
7. Deray, G.; LeHoang, P.; Soubrie, C.; Morer, I.; Cacoub, P.; Baumelou, A.; Rousselie, F.; Jacobs, C. Foscarnet-Induced Acute Renal Failure and Effectiveness of Haemodialysis. Lancet 1987, 2, 216.
8. Bowden, R. A.; Digel, J.; Reed, E. C.; Meyers, J. D. Immunosuppressive Effects of Ganciclovir on in vitro Lymphocyte Responses. J. Infect. Dis. 1987, 156, 899-903.
9. Field, A. K.; Biron, K. K. "The end of innocence" revisited: Resistance of herpesviruses to antiviral drugs. Clinical Microbiology Reviews 1994; 7:1-13.
10. (a) Townsend, L. B.; Revankar, G. R. Benzimidazole Nucleosides, Nucleotides, and Related Derivatives. Chem. Rev. 1970, 70, 389-438.
11. (b) Revankar, G. R., Townsend, L. B. The Synthesis of 2-Chloro-1-(β-D-ribofuranosyl)benzimidazole and Certain Related Derivatives. J. Heterocycl. Chem. 1968, 5, 477-483.
12. Beavan, G. R.; Holiday, E. R.; Johnson, E. A.; Ellis, B.; Mamalis, P.; Petrow, V.; Sturgeon, B. The chemistry of anti-pernicious anaemia factors Part III. 5:6-Disubstituted benzimidazoles as products of acid hydrolysis of vitamin B12. Journal of Pharmacy and Pharmacology 1949; 1:957-970.
13. Tamm, I.; Folkers, K.; Shunk, C. H.; Horsfall, F. L. Jr. Inhibition of Influenza Virus Multiplication by N-Glycosides of Benzimidazoles. J. Exp. Med. 1954, 99, 227-248.
14. Tamm, I.; Sehgal, P. B. Halobenzimidazole ribosides and RNA synthesis of cells and viruses. Advances in Virus Research 1978; 22:187-258.
15. (a) Townsend, L. B.; Devivar, R. V.; Turk, S. R.; Nassiri, M. R.; Drach, J. C. Design, Synthesis and Antiviral Activity of Certain 2,5,6-Trihalo-1-(β-D-ribofuranosyl)benzimidazoles. J. Med. Chem. 1995, 38, 4098-4105.
16. (b) Gudmundsson, K. S.; Drach, J. C.; Wotring, L. L.; Townsend, L.B. Synthesis and antiviral activity of certain 5′-modified analogs of 2,5,6,-trichloro-1-(ß-D-ribofuranosyl)benzimidazole (TCRB). J. Med. Chem. 1997, 40:785-793.
17. (c) Zou, R.; Drach, J. C.; Townsend, L.B. Design, synthesis and antiviral evaluation of 2-chloro-5,6-dihalo-1-(ß-D-ribofuranosyl)benzimidazoles as potential agents for human cytomegalovirus infections. J. Med. Chem 1997, 40, 811-818.
18. Underwood, M. R.; Harvey, R. J.; Stanat, S. C.; Hemphill, M. L.; Miller, T.; Drach, J. C.; Townsend, L. B.; Biron, K. K. Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product. J. Virol. 1998, 72:717-725.
19. Krosky, P. M.; Underwood, M. R.; Turk, S. R.; Feng, K. W.-H.; Jain, R. K.; Ptak, R. G.; Westerman, A. C.; Biron, K. K.; Townsend, L. B.; Drach, J. C. Resistance of human cytomegalovirus to benzimidazole nucleoside analogs maps to two open reading frames: UL89 and UL56. J. Virol. 1998, 72:4721-4728.
20. Horner, J. K.; Henry, D. W. Analogs of 3-Amino-7-chloro-1,2,4-benzotriazine 1-Oxide as Antimalarial Agents. J. Med. Chem. 1968, 11, 946-949.
21. Devivar, R. V. Design and Synthesis of 2-Substituted Analogs of 2,5,6-Trichloro-1-(β-D-ribofuranosyl)benzimidazole and Related Imidazo[4,5-b]pyridine Nucleosides as Potential Antiviral Agents for the Treatment of Human Cytomegalovirus Infections. Ph. D. Dissertation, University of Michigan, Ann Arbor, Michigan. 1992.
22. Mandel, L. R.; Porter, C. C.; Kuehl, F. A. Jr.; Jensen, N. P.; Schmitt, S. M.; Windholz, T. B.; Beattie, T. R.; Garty, J. A.; Christensen, B. G.; Shen, T. Y. Inhibition of Adrenal Phenethanolamine N-Methyltransferase by Substituted Benzimidazoles. J. Med. Chem. 1970, 13, 1043-1047.
23. Kawashima, E.; Gupta, P. K.; Devivar, R. V.; Townsend, L. B. Synthesis of a Precursor for 2-Substituted 5,6-Dichlorobenzimidazoles. In "Nucleic Acid Chemistry, Improved and New Synthetic Procedures, Methods and Techniques", Vol. 4, Townsend, L. B.; Tipson, R. S. Eds., Wiley-Interscience, New York, 1991, pp. 24-26.
24. 12, Purine, and Pyrimidine Requirement of Lactobacillus Leichmannii 313. Z. Naturforsch. 1951, 6b, 25-34.
25. Buchel, K. H. Inhibitors of Photosynthesis VI, Synthesis of Electronegatively Substituted Benzimidazoles. Z. Naturforsch. 1970, 25b, 945-953.
26. Pande, A. V.; Kirke, P. A.; Khadse, B. G. Synthesis and Study of 2-Benzylthio benzothiazoles and 2-Benzylthiobenzimidazoles as Antituberculosis Agents. Bull. Haffkine Inst. 1983, 11, 51-55.
27. Bednyagina, N. P.; Tyurenkova, G. N.; Panov, I. V. Benz- and Naphthazole Series. V. 5,6-Dimethyl-2-hydrazinobenzimidazole and its N-Alkylated Derivatives. Zh. Obshch. Khim. 1964, 34. 1575-1577. CA. 61: 8297a.
28. Bhat, C. C. Preparation of a Crystalline O-Acyl-2-deoxypentofuranosyl Halide. In "Synthetic Procedures in Nucleic Acid Chemistry", Vol. 1, Zorbach, W. W.; Tipson, R. S. Eds. Interscience Publishers, New York, 1968, pp. 521-522.
29. Kazimierczuk, Z.; Cottam, H. B.; Revankar, G. R.; Robins, R. K. Synthesis of 2′-Deoxytubercidin, 2′-Deoxyadenosine, and Related 2′-Deoxynucleosides via a Novel Direct Stereospecific Sodium Salt Glycosylation Procedure. J. Am. Chem. Soc. 1984, 706, 6379-6382.
30. Kazimierczuk, Z.; Stolarski, R.; Shugar, D. Stereospecific Synthesis by the Sodium Salt Glycosylation Method of Halogeno Benzimidazole 2′-Deoxyribose Analogues of the Inhibitor of hnRNA Synthesis, 5,6-Dichloro-1-(β-D-ribofuranosyl)benzimidazole (DRB). Z. Naturforsch. 1985, 40c, 715-720.
31. Rosemeyer, H.; Toth, G.; Seala, F. Assignment of Anomeric Configuration of D-ribo-, Arabino-, 2′-Deoxyribo-, and 2′,3′-Dideoxyribonucleosides by NOE Difference Spectroscopy. Nucleosides & Nucleotides, 1989, 8, 587-597.
32. Koszalka, G. W.; Chamberlain, S. D.; Daluge, S. M.; Boyd, F. L.; Tidwell, J. H.; Martin, M. T.; Harvey, R. J.; Frick, L. W.; Perkins, D. G.; Wang, L. H.; Drach, J. C.; Townsend, L. B.; Biron, K. K. Benzimidazoles for the treatment of human cytomegalovirus infection. XII International Roundtable: Nucleosides, Nucleotides and their Biological Applications, La Jolla, CA, September 1996.
33. Chan, J. H.; Chamberlain, S. D.; Davis, M. G.; Biron, K. K.; Harvey, R. J.; Selleseth, D. W.; Dornsife, R. E.; Dark, E. H.; Frick, L. W.; Koszalka, G. W.; Townsend, L. B.; Drach, J. C. Synthesis and evaluation of a series of 2′-Deoxy-(b-L-ribofuranosyl)benzimidazole analogues of the anti-HCMV agent 5,6-dichloro-2-iospropylamino-1-(β-L-ribofuranosyl) 1H benzimidazole (1263W94). Nucleosides & Nucleotides, 2000, submitted (this issue).
34. 12. J. Am. Chem. Soc. 1965, 87, 4940-4944.
35. Turk, S. R.; Shipman, C., Jr.; Nassiri, M. R.; Genzingler, G.; Krawczyk, S. H.; Townsend, L. B.; Drach, J. C. Pyrrolo[2,3-d]pyrimidine Nucleosides as Inhibitors of Human Cytomegalovirus, Antimicrob. Agents Chemother. 1987, 31, 544-550.
36. Prichard, M. N.; Turk, S. R.; Coleman, L. A.; Engelhardt, S. L.; Shipman, C., Jr.; Drach, J. C. A Microtiter Virus Yield Reduction Assay for the Evaluation of Antiviral Compounds Against Human Cytomegalovirus and Herpes Simplex Virus. J. Virol. Methods 1990, 28, 101-106.
37. Prichard, M. N.; Shipman, C., Jr. A Three Dimensional Model to Analyze Drug-Drug Interactions. Antiviral Res. 1990, 14, 181-206.
38. Prichard, M. N.; Prichard, L. E.; Baguley, W. A.; Nassiri, M. R.; Shipman, C., Jr. Three-Dimensional Analysis of the Synergistic Cytotoxicity of Ganciclovir and Zidovudine. Antiviral Res. 1991, 35, 1060-1065.
39. Cook, W. J.; Short, S. A.; Ealick, S. E. Crystallization and Preliminary X-ray Investigation of Recombinant Lactobacillus Leichmannii Nucleoside Deoxyribosyltransferase. Journal of Biological Chemistry 1990, 265, 2682-2683.